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Edited by Barry HalliwellAbstract A high-fat diet (HFD) is associated with reduced glu-
cose uptake in muscle, but not in adipose tissue. In the present
study, we investigated whether a HFD can modulate glucose up-
take in adipose tissue by increasing signal transduction through
the CAP/Cbl pathway, independently of the PI3-K/Akt pathway.
Our results suggest that, in HFD, the diﬀerential regulation of
insulin-induced glucose uptake between skeletal muscle and adi-
pose tissue may, in part, be a consequence of the CAP/Cbl/C3G
pathway, since the expression of CAP and Cbl, and also the acti-
vation of this pathway were increased in adipose tissue but not in
muscle.
 2006 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Over the last few years, it has been established that two path-
ways are necessary for insulin-stimulated glucose transport; a
phosphatidylinositol 3-kinase (PI3-K)-dependent pathway
and a PI3-K-independent pathway (reviewed in [1]).
In muscle and adipose tissue, the PI3-K-dependent pathway
is induced when activation of the insulin receptor by insulin re-
sults in tyrosine phosphorylation of several substrates, includ-
ing the insulin receptor substrate 1 (IRS-1), IRS-2 and IRS-3
(in the adipose tissue) (reviewed in [2]). Following tyrosine
phosphorylation, IRSs bind and activate the PI3-K enzyme.
Once activated, PI3-K mediates the increase in serine phos-
phorylation of protein kinase B (Akt), which, in turn, stimu-
lates glucose transport and lipogenesis (reviewed in [1,2]).
Recently, the proto-oncogene, Casitas b-lineage lymphoma
(Cbl), has been suggested to play a role in insulin action, inde-
pendently of the PI-3K/Akt pathway [3]. In 3T3-L1 adipo-Abbreviations: HFD, high-fat diet; WAT, white adipose tissue; 2DG,
2-deoxy-D-[1-14C] glucose; IR, insulin receptor; IRS, insulin receptor
substrate; PI3-K, phosphatidylinositol 3-kinase; Akt, protein kinase B;
Cbl, casitas b-lineage lymphoma; CAP, Cbl-associated protein; GL-
UT4, glucose transporter 4
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protein with Pleckstrin homology and Src homology 2 do-
mains (APS) and Cbl associated protein (CAP). Upon insulin
stimulation, this complex binds to the insulin receptor via an
interaction between an SH2 domain in APS and the tyrosyl-
phosphorylated receptor tail [4]. Cbl then undergoes
insulin-dependent tyrosine phosphorylation, resulting in the
recruitment of the CAP/Cbl complex to lipid rafts via an inter-
action between the CAP and the lipid raft protein ﬂotillin [5].
Within the lipid raft, tyrosyl-phosphorylated Cbl recruits the
CrkII/C3G heterodimer via an interaction between an SH2 do-
main in CrkII and a tyrosine phosphorylation site in Cbl [6].
C3G, a guanine nucleotide exchange factor for small molecular
weight GTPases, activates the small G protein TC10. The acti-
vation of TC10 provides a second signal to the glucose trans-
porter 4 (GLUT4) translocation and may function in parallel
with the activation of the PI3-K pathway [6].
In a previous study, we employed 2-deoxy-D-[1-14C] glucose
(2DG) uptake analysis to show that a high-fat diet induces a tis-
sue-speciﬁc regulation of glucose transportwith reduced glucose
uptake and insulin signaling inmuscle that is accompanied by an
increased insulin-stimulated glucose uptake in adipose tissue,
while the early steps of insulin signaling are not increased [7].
These results suggest that the molecular mechanism that ac-
counts for this increase in glucose transport in fat is independent
of the PI3-K/Akt pathway, since there is no modulation of this
pathway in the adipose tissue of high-fat diet (HFD) rats.
Thus, in the present study, we investigated the modulation
of the CAP/Cbl pathway in the muscle and adipose tissue of
HFD, and also evaluated if this pathway may account for in-
creased glucose uptake in adipocytes of these animals.2. Materials and methods
2.1. Materials
Male Wistar rats were provided by the State University of Campinas
– Central Breeding Center (Campinas, SP, Brazil). Anti-phosphotyro-
sine (a-PY), anti-IRb (a-IR), anti-IRS-1, anti-IRS-2, anti-IRS-3, anti-
c-Cbl (a-Cbl), anti-CAP (a-CAP), anti-Akt1/2, anti-phospho-C3G and
anti-GLUT4 antibodies were from Santa Cruz Technology (Santa
Cruz, CA, USA). Anti-phospho-Akt antibody was from Cell Signaling
Technology (Beverly, MA, USA). Human recombinant insulin was
from Eli Lilly and Co. (Indianapolis, IN, USA). Routine reagents were
purchased from Sigma Chemical Co. (St. Louis, MO, USA) unless
speciﬁed elsewhere. 125I-Protein A and 2-deoxy-D-[1-14C] glucose were
obtained from Amersham (Amersham Pharmacia Biotech-United
Kingdom-Ltd. Buckinghamshire, UK).blished by Elsevier B.V. All rights reserved.
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All experiments were approved by the Ethics Committee at the State
University of Campinas.
Eight-week-old male Wistar rats were divided into two groups
with similar body weights (250 ± 5 g) and assigned to receive water
ad libitum and two kinds of diet: a standard rodent chow (C) (carbo-
hydrate: 70%; protein: 20%; fat: 10%, totaling 3.8 kcal/g) or a HFD
(carbohydrate: 38.5%; protein: 15%; fat: 46.5%, totaling 5.4 kcal/g)
for 30 days.2.3. Animal characterization
At the end of the diet period, the body weight and epididymal fat
pad were measured. Food was withdrawn 12 h before the experiments
and blood samples were taken for the determination of the serum con-
centration of insulin and glucose levels. Blood glucose levels were mea-
sured by the glucose oxidase method [8]. Serum insulin was determined
by radioimmunoassay.Table 1
Animal characteristics
Control HFD2.4. Hyperinsulinemic-euglycemic clamp procedures
After 12 h of fasting, animals were anesthetized intraperitoneally
with a mix of ketamin (100 mg) and diazepam (0.07 mg) (0.2 ml/
100 g body weight) and catheters were then inserted into the left jugu-
lar vein (for tracer infusions) and carotid artery (for blood sampling),
as previously described [9]. Experiments were started when glycemia
had returned to stable levels, 30 min after the end of the surgical pro-
cedure. A 120-min hyperinsulinemic-euglycemic clamp procedure was
conducted in anesthetized catheterized rats, as shown previously
[7,9], with a prime continuous infusion of human insulin at a rate of
3.6 mU/kg body wt/min to raise the plasma insulin concentration to
approximately 800–900 pmol/l. Blood samples (20 ll) were collected
at 5-min intervals for the immediate measurement of plasma glucose
concentration, and 10% unlabeled glucose was infused at variable rates
to maintain plasma glucose at fasting levels. To estimate insulin-stim-
ulated glucose-transport activity and metabolism in skeletal muscle
and adipose tissue, 2-deoxy-D-[1-14C] glucose was administrated as a
bolus (10 lCi) 45 min before the end of the clamp procedure. All infu-
sions were performed using Harvard infusion pumps. At the end of the
clamp procedure, animals were killed by a mix of ketamin and diaze-
pam intravenous injection. Within 2 min, two skeletal muscles (soleus
and gastrocnemius) from both hind limbs and epididymal white adi-
pose tissue were taken. Each tissue, once exposed, was dissected out
within 2 s, weighed, frozen with liquid N2 and stored at 80 C for
later analysis.
2.5. Analytical procedures of hyperinsulinemic-euglycemic clamp
Plasma glucose was measured using a glucometer (Advantage, Boeh-
ringer Mannheim, USA). The whole blood glucose uptake was ob-
tained from averaged rates of the last 30 min of 10% unlabeled
glucose infusion during clamp procedures. Glucose transport activity
in skeletal muscle and in adipose tissue was calculated from the tissue
2DG proﬁle, as described before [7,10].
2.6. Tissue extraction and immunoprecipitation
Rats were anesthetized with a mix of ketamin (100 mg) and diaze-
pam (0.07 mg) (0.2 ml/100 g body weight) and used 10–15 min later.
As soon as anesthesia was assured by the loss of pedal and corneal re-
ﬂexes, the abdominal cavity was opened, the portal vein was exposed
and 0.2 ml of normal saline with or without 106 M insulin was in-
jected. 90 s and 5 min after the insulin injection, the skeletal muscle
and the adipose tissue were removed, minced coarsely and homo-
genized immediately in extraction buﬀer, as described elsewhere [7].
Extracts were then centrifuged at 11000 rpm and 4 C for 40 min to
remove insoluble material and the supernatants were used for immuno-
precipitation with a-IR, a-IRS-1, a-IRS-2, a-IRS-3, a-Cbl and Protein
A-Sepharose 6MB (Amersham Pharmacia Biotech-United Kingdom-
Ltd Buckinghamshire, UK).Body weight (g) 286.8 ± 7.4 343.2 ± 4.1*
Epididymal fat (g/100 g) 1.2 ± 0.08 1.7 ± 0.1**
Blood glucose (mg/dl) 88 ± 3 96 ± 5
Serum insulin (pmol/l) 8.8 ± 1.5 19.2 ± 2.1**
Data are means ± S.E.M. Each group was composed of 5–7 animals.
*HFD vs. C, P < 0.0001.
**HFD vs. C, P < 0.01.2.7. Protein analysis by immunoblotting
The precipitated proteins and/or whole tissue extracts were treated
with Laemmli sample buﬀer [11] containing 100 mM DTT and heated
in a boiling water bath for 5 min, after which they were subjected to
SDS–PAGE in a Bio-Rad miniature slab gel apparatus (Mini-Pro-
tean). For total extracts, 250 lg proteins were subjected to SDS–PAGE. Electrotransfer of proteins from the gel to nitrocellulose was
performed for 120 min at 120 V in a Bio-Rad Mini-Protean transfer
apparatus [12]. Non-speciﬁc protein binding to the nitrocellulose was
reduced by pre-incubating the ﬁlter for 2 h in blocking buﬀer (5% non-
fat dry milk, 10 mM Tris, 150 mM NaCl, 0.02% Tween20). The nitro-
cellulose blot was incubated with speciﬁc antibodies overnight at 4 C
and then incubated with 125I-Protein A. The results were visualized by
autoradiography with preﬂashed Kodak XAR ﬁlm. Band intensities
were quantiﬁed by optical densitometry (Hoefer Scientiﬁc Instruments,
San Francisco, USA; model GS300).
2.8. Plasma membrane GLUT4 determination
To characterize the expression and subcellular localization of
GLUT4, a subcellular fractionation protocol was employed as de-
scribed previously [13] with minor modiﬁcations. Fragments of skeletal
muscle and adipose tissue from untreated rats or rats treated with insu-
lin (0.2 ml, 106 M, tissue obtained 15 min after insulin infusion),
according to the protocols described above, were minced and homog-
enized in 2 vol. of STE buﬀer (0.32 M sucrose, 20 mM Tris–HCl (pH
7.4), 2 mM EDTA, 1 mM DTT, 100 mM sodium ﬂuoride, 100 mM
sodium pyrophosphate, 10 mM sodium orthovanadate, 1 mM PMSF,
and 0.1 mg aprotinin/ml] at 4 C with a Polytron homogenizer. The
homogenates were centrifuged (1000 · g, 25 min, 4 C) to obtain pel-
lets. The pellets were washed once with STE buﬀer (1000 · g, 10 min,
4 C) and suspended in Triton buﬀer (1% Triton X-100, 20 mM
Tris–HCl (pH 7.4), 150 mM NaCl, 200 mM EDTA, 10 mM sodium
orthovanadate, 1 mM PMSF, 100 mM NaF, 100 mM sodium pyro-
phosphate, and 0.1 mg aprotinin/ml), kept on ice for 30 min, and cen-
trifuged (15000 · g, 30 min, 4 C) to obtain the nuclear fraction. The
supernatant was centrifuged (100000 · g, 60 min, 4 C) to obtain the
cytosol fraction and the pellet, which was suspended in STE buﬀer
1% NP-40, kept on ice for 20 min, and centrifuged (100000 · g,
20 min) to obtain the membrane fraction. The fractions were treated
with Laemmli buﬀer with 100 mM DTT and heated in a boiling water
bath for 5 min, and aliquots (100 lg of protein) were subjected to
SDS–PAGE and Western blotting with anti-GLUT4 antibody, as
described elsewhere [14].
2.9. Statistical analysis
Data are expressed as means ± S.E.M. accompanied by the indicated
number of independent experiments. For statistical analysis, the
groups were compared using t test or one-way ANOVA with the Bon-
ferroni test for post hoc comparisons. The level of signiﬁcance adopted
was P < 0.05.3. Results
3.1. Animal characteristics
Table 1 shows that the body weight (P < 0.0001), the epidid-
ymal fat (P < 0.01) and the fasting serum insulin levels
(P < 0.01) were higher in HFD rats than in control rats, de-
spite their similar fasting blood glucose levels.
3.2. Hyperinsulinemic-euglycemic clamp procedures in
combination with 2DG infusion
The glucose infusion rate needed to clamp glycemia at fast-
ing levels in the presence of a constant infusion of insulin
Fig. 1. Steady-state glucose infusion rates obtained from averaged rates of 90–120 min of 10% unlabeled glucose infusion during hyperinsulinemic-
euglycemic clamp procedures in control rats (C) and in rats fed on HFD for 30 days (A). Glucose transport in skeletal muscle and in adipose tissue
evaluated by 2DG uptake during the last 45 min of the hyperinsulinemic-euglycemic clamp studies (B). Data are means ± S.E.M. of ﬁve independent
experiments.  HFD vs. C, P < 0.01; * HFD vs. C, P < 0.0001;  HFD vs. C, P < 0.001.
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3.5 ± 1.1 mg/kg/min, P < 0.01; Fig. 1A) in rats fed on the
HFD than in their respective controls.
As shown in Fig. 1B, there was a signiﬁcant decrease (C:
200 ± 15; HFD: 50 ± 12 gmol/g/min, P < 0.0001) in glucose
uptake in the muscle of HFD rats when compared with the
control animals. In contrast, the adipose tissue showed a sig-
niﬁcantly higher (C: 148 ± 10; HFD: 250 ± 15 gmol/g/min,
P < 0.001) glucose uptake in HFD rats when compared with
the control animals.
3.3. Insulin signaling in the adipose tissue of controls and HFD-
treated rats
There were no diﬀerences in IR protein levels nor in insulin-
induced IR tyrosine phosphorylation in the adipose tissue of
HFD and control animals (Fig. 2A and B).
Despite similar levels of IRS-1 in the adipose tissue of ani-
mals fed on the HFD and on the control diet, there was a
decrease in insulin-stimulated IRS-1 tyrosine phosphorylation
(C: 100 ± 1.3%; HFD: 60 ± 1.1%, P < 0.001; Fig. 2C) and in
IRS-1/PI3-K association (C: 100 ± 1.1%; HFD: 64 ± 1%,
P < 0.001; Fig. 2D) when compared with the control group.
There were no diﬀerences in IRS-2 protein levels in the adipose
tissue of HFD rats, compared with controls. Animals fed on
the HFD presented insulin-stimulated IRS-2 tyrosine phos-
phorylation and association of the IRS-2/PI3-K in a similar
to control animals (Fig. 2E and F). There were no diﬀerences
in IRS-3 protein levels in the adipose tissue of HFD rats, com-
pared with controls. However, animals fed on the HFD pre-
sented a decrease in insulin-stimulated IRS-3 tyrosine
phosphorylation (C: 100 ± 6%; HFD: 45 ± 9.4%, P < 0.001;
Fig. 2G) and a decrease in IRS-3/PI3-K association (C:
100 ± 15%; HFD: 42 ± 5.2%, P < 0.001; Fig. 2H) compared
to control animals.
There were no diﬀerences in Akt protein levels nor in insulin-
induced Akt serine phosphorylation in the adipose tissue of
HFD, compared to control animals (Fig. 2I).
3.4. The CAP/Cbl pathway in the adipose tissue of controls and
HFD-treated rats
There were increases in Cbl (C: 100 ± 5%; HFD: 150 ± 3%,
P < 0.0001; Fig. 3A) and CAP (C: 100 ± 3%; HFD:140 ± 2.5%, P < 0.0001; Fig. 3B) protein expressions in adi-
pose tissue from HFD rats, compared to control rats. There
was also an increase in insulin-stimulated c-Cbl tyrosine phos-
phorylation (C: 100 ± 1.1%; HFD: 200 ± 1.5%, P < 0.001;
Fig. 3C) in the fat of HFD-fed rats compared with control
rats. In addition, there was an increase in CAP/Cbl association
(C: 100 ± 14%; HFD: 200 ± 23%, P < 0.001; Fig. 3D) in the
HFD group, compared to control group. We also observed
an increase in insulin-stimulated C3G tyrosine phosphoryla-
tion (C: 100 ± 0.8%; HFD: 190 ± 1.7%, P < 0.001; Fig. 3E)
in the adipose tissue of HFD-fed rats compared with control
rats. In subcellular fractionation studies, there was an insu-
lin-dependent increase of GLUT4 in the membrane fraction
(C: 158 ± 1.3%; HFD: 180 ± 1.1%, P < 0.05; Fig. 3F) in the
adipose tissue of HFD-fed rats compared to control rats.
3.5. Insulin signaling and CAP/Cbl pathway in the skeletal
muscle of controls and HFD-treated rats
There were no diﬀerences in IR protein levels in the muscles
of HFD and control animals (Fig. 4A); however, animals fed
on a HFD showed a signiﬁcantly reduced insulin-stimulated
IR tyrosine phosphorylation in muscle (C: 100 ± 1%; HFD:
51 ± 1.3%, P < 0.001; Fig. 4B) compared with control rats.
Despite similar levels of IRS-1 in the skeletal muscle of ani-
mals fed on a HFD and those on the control diet (Fig. 4C),
there was a decrease in insulin-stimulated IRS-1 tyrosine phos-
phorylation (C: 100 ± 5.3%; HFD: 40 ± 2.1%, P < 0.001;
Fig. 4C) and in IRS-1/PI3-K association (C: 100 ± 0.7%;
HFD: 42 ± 1%, P < 0.001; Fig. 4D) when compared with the
control group. There were no diﬀerences in IRS-2 protein lev-
els in the skeletal muscle of HFD rats, compared with controls
(Fig. 4E). In contrast, there was a signiﬁcant reduction in insu-
lin-stimulated IRS-2 tyrosine phosphorylation (C: 100 ± 2%;
HFD: 52 ± 1.1%, P < 0.001 Fig. 4E) and in IRS-2/PI3-K asso-
ciation when compared with control animals (C: 100 ± 3.1%;
HFD: 50 ± 4.8%, P < 0.001 Fig. 4F). There were no diﬀerences
in Akt protein levels (Fig. 4G). However, there was a reduction
in insulin-stimulated Akt serine phosphorylation in animals
fed on a HFD, when compared with controls (C: 100 ± 6%;
HFD: 30 ± 2%, P < 0.001 Fig. 4G).
When we performed immunoprecipitation of whole
tissue extracts with anti-Cbl and immunoblotting with
Fig. 2. Insulin signaling in the adipose tissue of control animals and
rats fed on a HFD for 30 days. IP with a-IR and IB with a-IR
antibodies (A); IP with a-IR and IB with a-pY antibodies (B); IP with
a-IRS-1 and IB with a-IRS-1 and IP with a-IRS-1 and IB with a-pY
antibodies (C); IP with a-IRS-1 and IB with a-PI3-K antibodies (D);
IP with a-IRS-2 and IB with a-IRS-2 and IP with a-IRS-2 and IB with
a-pY antibodies (E); IP with a-IRS-2 and IB with a-PI3-K antibodies
(F); IP with a-IRS-3 and IB with a-IRS-3 and IP with a-IRS-3 and IB
with a-pY antibodies (G); IP with a-IRS-3 and IB with a-PI3-K
antibodies (H.); IB with a-Akt1/2 antibody and IB with a-pAkt
Fig. 3. CAP/Cbl pathway in the adipose tissue of control animals and
rats fed on a HFD for 30 days. IB with a-c-Cbl antibody (A); IB with
a-CAP antibody (B); IP with a-c-Cbl and IB with a-pY antibodies (C);
IP with a-c-Cbl and IB with a-CAP antibodies (D); IB with a-pC3G
antibody (E); IB with a-GLUT4 antibody in the plasma membrane
(F). Data are means ± S.E.M. of six independent experiments. * HFD
vs. C, P < 0.0001; # HFD vs. C, P < 0.001; § HFD+ vs. C+,
P < 0.001;  HFD vs. C, P < 0.05;  HFD+ vs. C+, P < 0.05. IP,
immunoprecipitation; IB, immunoblotting.
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duced Cbl tyrosine phosphorylation. In addition, CAP protein
expression and insulin-induced C3G tyrosine phosphorylation
could not be detected by blotting whole tissue extracts with
anti-CAP and anti-phospho-C3G antibodies (data not shown).
However, when we used the plasma membrane fraction for
immunoprecipitation with anti-Cbl antibody, insulin-induced
Cbl tyrosine phosphorylation was detected in the skeletal mus-
cle. In this experiment with the plasma membrane fraction,
there was a decrease in insulin-stimulated c-Cbl tyrosine phos-
phorylation in the skeletal muscle in HFD rats compared to
control rats (C: 100 ± 1.1%; HFD: 60 ± 1.5%, P < 0.001;
Fig. 4H). We also observed, in the subcellular fractionation
studies, that there was an insulin-dependent decrease of
GLUT4 in the membrane fraction (C: 100 ± 4%; HFD:
88 ± 1.9%, P < 0.05; Fig. 4I) in the skeletal muscle of HFD-
fed rats compared to control rats.N 
antibody (I). Data are means ± S.E.M. of six independent experiments.
* HFD
+ vs. C+, P < 0.001; # HFD vs. C, P < 0.05. IP, immuno-
precipitation; IB, immunoblotting.
Fig. 4. Insulin signaling and CAP/Cbl pathway in the skeletal muscle
of control animals and rats fed on a HFD for 30 days. IP with a-IR
and IB with a-IR antibodies (A); IP with a-IR and IB with a-pY
antibodies (B); IP with a-IRS-1 and IB with a-IRS-1 and IP with a-
IRS-1 and IB with a-pY antibodies (C); IP with a-IRS-1 and IB with
a-PI3-K antibodies (D); IP with a-IRS-2 and IB with a-IRS-2 and IP
with a-IRS-2 and IB with a-pY antibodies (E); IP with a-IRS-2 and IB
with a-PI3-K antibodies (F); IB with a-Akt1/2 antibody and IB with a-
pAkt antibody (G); IP with a-c-Cbl and IB with a-c-Cbl antibody and
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High fat intake is associated with a tissue-speciﬁc insulin
resistance, characterized by reduced insulin sensitivity in liver,
muscle, hypothalamus, but not in adipose tissue, at least dur-
ing the ﬁrst month of a high-fat diet [7]. Moreover, the white
adipose tissue (WAT) of HFD-rats is more sensitive to insulin
action during euglycemic hyperinsulinemic clamp conditions,
where glucose utilization is dramatically increased [7]. The
molecular mechanism that may account for this increase in
glucose uptake in WAT, despite the existence of skeletal mus-
cle and whole body insulin resistance, is not well established.
In this study, we associated functional studies of insulin sensi-
tivity with immunoblotting, to investigate which pathways are
involved in this tissue-speciﬁc regulation of glucose transport
in the adipose tissue and in skeletal muscle of high-fat-diet
rats.
Our data show that, in the adipose tissue of HFD-animals,
there is an increase in CAP and Cbl protein expression, and
a further increase in insulin-induced Cbl tyrosine phosphoryla-
tion, in CAP/Cbl association and in C3G tyrosine phosphory-
lation, indicating an increased activity of this pathway. Since
this pathway may have an important role in glucose uptake
in adipocytes [15,16], we may suggest that its increased activ-
ity, in parallel to an increase in insulin-induce GLUT4 in the
membrane fraction in adipose tissue of HFD-fed rats com-
pared to controls, may explain the increased glucose utilization
during the euglycemic hyperinsulinemic clamp, and also the in-
creased adiposity of HFD-rats. In accordance with these data,
recent reports show that, in c-Cbl or CAP knockout mice on a
high-fat diet there is a smaller increase in adiposity than in
wild-type mice [17,18].
The increase in glucose uptake in adipose tissue contrasts
with the ability of insulin to stimulate the IRS-1 and IRS-3
tyrosine phosphorylation. In a previous study in human adipo-
cytes from type 2 diabetic patients, a remarkable reduction in
IRS-1 protein expression and tyrosine phosphorylation was
demonstrated. In this case, IRS-2 was able to replace IRS-1
as the main docking protein for binding and activation of
PI3-K [19]. In accordance, our results showed no alteration
in insulin-induced IRS-2 tyrosine phosphorylation and the
association with PI3-K. Since Akt, the downstream eﬀector
of the IRSs/PI3-K pathway showed a similar insulin-induced
serine phosphorylation in the adipose tissue of HFD animals,
we may suggest that IRS-2 may replace the reduction in IRS-1
and IRS-3 tyrosine phosphorylation in these animals.
The reduction in insulin signaling, through IRS-1 and IRS-3,
and the absence of any alteration in the IRS-2/Akt pathway
contrasts with the ability of insulin to stimulate the CAP/
Cbl/C3G pathway in the adipose tissue of high fat diet-fed rats.
In this regard, it is important to emphasize that, in the adipose
tissue of HFD rats, no alteration was observed in insulin-in-
duced insulin receptor phosphorylation. Moreover, the expres-
sions of CAP and Cbl were higher in the adipose tissue of
these rats, probably contributing to the increase in the
insulin-induced activation of this pathway. A reduction inN 
IP with a-c-Cbl and IB with a-pY antibody in the plasma membrane
(H); IB with a-GLUT4 antibody in the plasma membrane (I). Data are
means ± S.E.M. of six independent experiments. * HFD
+ vs. C+,
P < 0.001,  HFD+ vs. C+, P < 0.05. IP, immunoprecipitation; IB,
immunoblotting.
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ported in adipose and cardiac tissues from ob/ob mice [20];
however, in these mice, there was a signiﬁcant reduction in
the level of insulin receptor tyrosine phosphorylation in both
tissues. This reduction is likely to account for the lower
Cbl phosphorylation seen in ob/ob following insulin admin-
istration.
In a previous study, we showed that plasma insulin levels are
paralleled by Cbl protein expression, tyrosine phosphorylation
and association with CAP [21]. The result of the present study
reinforces these data showing that, in HFD-rats, an hyperins-
ulinemic animal model of insulin resistance, there is an increase
in the activity of the CAP/Cbl/C3G pathway in adipose tissue.
The reduced glucose uptake in muscle of HFD was accompa-
nied by a decrease in insulin-induced IR/IRSs/PI-3K/Akt path-
way. The reduced activity of this pathway has biological
importance because it is related to glucose transport in muscle.
In accordance, our data also demonstrated an insulin-depen-
dent decrease of GLUT4 in the plasma membrane fraction in
the skeletal muscle of HFD-fed rats compared to control rats.
In a previous paper [21] and in the present study we did not
detect insulin-induced Cbl tyrosine phosphorylation in immu-
noprecipitates of whole tissue extracts of skeletal muscle. On
the other side, in accordance with Bernard et al. [22] we
showed insulin-induced Cbl tyrosine phosphorylation in plas-
ma membrane immunoprecipitates of skeletal muscle of rats,
and a reduction in this protein phosphorylation level in the
muscle of HFD rats. However, we did not observe insulin-in-
duced C3G tyrosine phosphorylation in this tissue in controls
nor in HFD rats. Cbl activation has been previously demon-
strated in perfused hindlimb muscle, but downstream signaling
such C3G tyrosine phosphorylation or TC10 activation were
not examined [22]. Gupte and Mora recently demonstrated
that TC10 is not activated in skeletal muscle, despite the tyro-
sine phosphorylation of Cbl in response to insulin [20]. In
accordance with this, glucose transport is not reduced in iso-
lated skeletal muscle from c-Cbl knockout mice [23], suggest-
ing that the Cbl/CAP/C3G/TC10 pathway may not have an
important role in regulating glucose uptake in this tissue.
In conclusion, we may suggest that, in HFD, the diﬀerential
regulation of insulin-induced glucose uptake between skeletal
muscle and adipose tissue may in part be the consequence of
the CAP/Cbl/C3G pathway, since the expression of CAP and
Cbl, and also the activation of this pathway, were increased
in adipose tissue but not in muscle.
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